Items where authors include "Bauer, D.C."

Article

Schini, M. orcid.org/0000-0003-2204-2095, Lui, L.-Y., Vilaca, T. orcid.org/0000-0002-9227-6076 et al. (6 more authors) (2025) The relationship between baseline bone mineral density and fracture incidence in the placebo groups of randomized controlled trials using individual patient data from the FNIH-ASBMR-SABRE project. Journal of Bone and Mineral Research, 40 (3). pp. 307-314. ISSN 0884-0431

Vilaca, T. orcid.org/0000-0002-9227-6076, Schini, M. orcid.org/0000-0003-2204-2095, Lui, L.-Y. et al. (7 more authors) (2024) The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project. Journal of Bone and Mineral Research, 39 (10). pp. 1434-1442. ISSN 0884-0431

Schini, M. orcid.org/0000-0003-2204-2095, Vilaca, T. orcid.org/0000-0002-9227-6076, Lui, L.-Y. et al. (7 more authors) (2024) Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project. Journal of Bone and Mineral Research, 39 (7). pp. 867-876. ISSN 0884-0431

Schini, M. orcid.org/0000-0003-2204-2095, Vilaca, T. orcid.org/0000-0002-9227-6076, Vittinghoff, E. et al. (7 more authors) (2024) Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project. Journal of Bone and Mineral Research, 39 (5). pp. 544-550. ISSN 0884-0431

Eastell, R. orcid.org/0000-0002-0323-3366, Black, D.M., Lui, L. et al. (9 more authors) (2021) Treatment‐related changes in bone turnover and fracture risk reduction in clinical trials of antiresorptive drugs: proportion of treatment effect explained. Journal of Bone and Mineral Research, 36 (2). pp. 236-243. ISSN 0884-0431

Kim, T.Y., Bauer, D.C., McNabb, B.L. et al. (4 more authors) (2019) Comparison of BMD changes and bone formation marker levels 3 years after bisphosphonate discontinuation: FLEX and HORIZON-PFT Extension I trials. Journal of Bone and Mineral Research, 34 (5). pp. 810-816. ISSN 0884-0431

Rodriguez, A.J., Fink, H.A. orcid.org/0000-0002-5985-5447, Mirigian, L. et al. (5 more authors) (2017) Pain, quality of life and safety outcomes of kyphoplasty for vertebral compression fractures: report of a task force of the American Society for Bone and Mineral Research. Journal of the Peripheral Nervous System, 32 (9). pp. 1935-1944. ISSN 0884-0431

Blum, M.R., Bauer, D.C., Collet, T-H. et al. (31 more authors) (2015) Subclinical Thyroid Dysfunction and Fracture Risk: A Meta-analysis. The Journal of the American Medical Association (JAMA), 313 (20). pp. 2055-2065. ISSN 0098-7484

Jacques, R.M., Boonen, S., Cosman, F. et al. (4 more authors) (2012) Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT). Journal of Bone and Mineral Research, 27 (8). 1627 - 1634. ISSN 1523-4681

Austin, M., Yang, Y.C., Vittinghoff, E. et al. (19 more authors) (2012) Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. Journal of Bone and Mineral Research (JBMR), 27 (3). pp. 687-693. ISSN 0884-0431

Proceedings Paper

Vilaca, T., Toronjo Schini, M., Thompson, A.R. et al. (7 more authors) (2024) 7867 Treatment-related changes in total hip bone mineral density and fracture risk reduction for drugs with different mechanisms of action: the FNIH-ASBMR-SABRE project. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .